Jaksic Karisik M, Lazarevic M, Mitic D, Milosevic Markovic M, Riberti N, Jelovac D
Cells. 2025; 14(2).
PMID: 39851519
PMC: 11763652.
DOI: 10.3390/cells14020091.
Etzi F, Grinan-Lison C, Fenu G, Gonzalez-Titos A, Pisano A, Farace C
Cancers (Basel). 2025; 16(24.
PMID: 39766136
PMC: 11674241.
DOI: 10.3390/cancers16244237.
Bhagtaney L, Dharmarajan A, Warrier S
Cancers (Basel). 2024; 16(5).
PMID: 38473318
PMC: 10931375.
DOI: 10.3390/cancers16050957.
Weeramange C, Tang K, Barrero R, Hartel G, Liu Z, Ladwa R
Cancer Med. 2023; 12(14):15128-15140.
PMID: 37278132
PMC: 10417169.
DOI: 10.1002/cam4.6185.
Hung C, Tsai T, Lee K, Hsu Y
Biomedicines. 2023; 11(4).
PMID: 37189614
PMC: 10135833.
DOI: 10.3390/biomedicines11040996.
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity.
Park C, Lee M, Lee S, Kang D, Park S, Lee D
Noncoding RNA Res. 2023; 8(3):273-281.
PMID: 36949748
PMC: 10025963.
DOI: 10.1016/j.ncrna.2023.03.001.
Mapping Research on miRNAs in Cancer: A Global Data Analysis and Bibliometric Profiling Analysis.
Shaw P, Lokhotiya K, Kumarasamy C, Sunil K, Suresh D, Shetty S
Pathophysiology. 2022; 29(1):66-80.
PMID: 35366290
PMC: 8950962.
DOI: 10.3390/pathophysiology29010007.
miR-30a/SOX4 Double Negative Feedback Loop is modulated by Disulfiram and regulates EMT and Stem Cell-like properties in Breast Cancer.
Liu Z, Mi M, Zheng X, Zhang C, Zhu F, Liu T
J Cancer. 2021; 12(16):5053-5065.
PMID: 34234874
PMC: 8247377.
DOI: 10.7150/jca.57752.
miR-186 Inhibits Liver Cancer Stem Cells Expansion Targeting PTPN11.
Yao H, Yang Z, Lou Y, Huang J, Yang P, Jiang W
Front Oncol. 2021; 11:632976.
PMID: 33816273
PMC: 8012905.
DOI: 10.3389/fonc.2021.632976.
The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma.
Dinneen K, Baird A, Ryan C, Sheils O
Front Mol Biosci. 2021; 8:600373.
PMID: 33628765
PMC: 7897661.
DOI: 10.3389/fmolb.2021.600373.
Therapeutic advances of miRNAs: A preclinical and clinical update.
Chakraborty C, Sharma A, Sharma G, Lee S
J Adv Res. 2020; 28:127-138.
PMID: 33364050
PMC: 7753224.
DOI: 10.1016/j.jare.2020.08.012.
Repression of Irs2 by let-7 miRNAs is essential for homeostasis of the telencephalic neuroepithelium.
Fernandez V, Martinez-Martinez M, Prieto-Colomina A, Cardenas A, Soler R, Dori M
EMBO J. 2020; 39(21):e105479.
PMID: 32985705
PMC: 7604626.
DOI: 10.15252/embj.2020105479.
Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines.
Pajuelo-Lozano N, Alcala S, Sainz Jr B, Perona R, Sanchez-Perez I
Theranostics. 2020; 10(21):9601-9618.
PMID: 32863948
PMC: 7449921.
DOI: 10.7150/thno.49270.
MicroRNA-214-3p inhibits the stem-like properties of lung squamous cell cancer by targeting YAP1.
Lu T, Yang Y, Li Z, Lu S
Cancer Cell Int. 2020; 20:413.
PMID: 32863772
PMC: 7450582.
DOI: 10.1186/s12935-020-01506-2.
Expression of miRNA in 5-FU resistant esophageal cancer.
Mahawongkajit P, Tomtitchong P
Mol Clin Oncol. 2020; 13(2):221-227.
PMID: 32714549
PMC: 7366237.
DOI: 10.3892/mco.2020.2070.
Cellular Plasticity in Breast Cancer Progression and Therapy.
Kong D, Hughes C, Ford H
Front Mol Biosci. 2020; 7:72.
PMID: 32391382
PMC: 7194153.
DOI: 10.3389/fmolb.2020.00072.
The Interplay among miRNAs, Major Cytokines, and Cancer-Related Inflammation.
Chakraborty C, Sharma A, Sharma G, Lee S
Mol Ther Nucleic Acids. 2020; 20:606-620.
PMID: 32348938
PMC: 7191126.
DOI: 10.1016/j.omtn.2020.04.002.
Exosomal miRNA-128-3p from mesenchymal stem cells of aged rats regulates osteogenesis and bone fracture healing by targeting Smad5.
Xu T, Luo Y, Wang J, Zhang N, Gu C, Li L
J Nanobiotechnology. 2020; 18(1):47.
PMID: 32178675
PMC: 7077029.
DOI: 10.1186/s12951-020-00601-w.
MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
You X, Zhou Z, Chen W, Wei X, Zhou H, Luo W
Stem Cell Res Ther. 2020; 11(1):117.
PMID: 32171324
PMC: 7071696.
DOI: 10.1186/s13287-020-1576-3.
Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients.
Farace C, Pisano A, Grinan-Lison C, Solinas G, Jimenez G, Serra M
Oncotarget. 2020; 11(2):116-130.
PMID: 32010426
PMC: 6968784.
DOI: 10.18632/oncotarget.27411.